o2h Ventures is an established fund manager based in the heart of the biotech community in Cambridge, UK.
o2h Ventures Limited is authorised by the Financial Conduct Authority (FRN 812245). We are a specialist fund that invests in biotech therapeutics and the intersection between biotechnology and AI/ML. o2h Ventures was launched in 2018 to provide pre-seed and seed capital to Great British biotech innovations. To date the fund and pre-fund has invested into over 28 biotech therapeutic companies of which two have clinical proof of concept data, and one has listed on the public markets.
o2h Ventures has two specialist tax efficient funds open for investment on a 6 monthly basis – The o2h human health SEIS Fund and The o2h human health EIS knowledge-intensive Fund
The focus of o2h Ventures is to seek out biotech therapeutic opportunities within the UK and then support these ventures through investment and connections into the pharmaceutical industry. Our aim has been to find exciting early-stage opportunities that can be nurtured in the UK biotech ecosystem and thus build a pipeline of innovative medicines and investment opportunities for later stage funds and pharmaceutical companies to invest into or acquire. We have focused on de-risking the investments by understanding areas of high interest to big pharma and then providing ‘hands-on’ support via team building, mentoring, fundraising, scientific support and seeking commercial partnerships.
Interested investors or companies that would like to be considered for funding can contact us at: firstname.lastname@example.org